Literature DB >> 30076783

Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

G Elias1,2, A Souquette3, S Heynderickx1, I De Meester4, H Jansens5, P Beutels6,2, P Van Damme2,7, E Smits1,2,8, P G Thomas3, V Van Tendeloo1,2, B Ogunjimi1,6,2,9.   

Abstract

Pathogen exposure, including but not limited to herpesviruses, moulds the shape of the immune system, both at a basal state and in response to immune challenge. However, little is known about the impact of high exposure to other viruses on baseline immune signatures and how the immune system copes with repetitive exposures to maintain a balanced functionality. Here we investigated baseline immune signatures, including detailed T cell phenotyping, antigen-specific CD4+ and CD8+ T cell responses and cytokine profile in paediatric (PED) nurses, who have high occupational exposure to viral pathogens including varicella zoster virus (VZV) and respiratory viruses, and in neonatal intensive care unit (NICU) nurses, as a control group with infrequent occupational exposure. Our results show a lower CD4+ T cell response to two VZV proteins (IE62 and gE) and to tetanus toxoid (TT) in PED nurses who are cytomegalovirus (CMV)-seronegative, compared to CMV-seronegative NICU nurses, and that the decline might be more pronounced the more sustained the exposure. This decline might be due to an attrition of VZV- and TT-specific T cells as a result of the continuous pressure on the CD4+ T cell compartment. Moreover, our data suggest that the distinct T cell phenotypes known to be associated with CMV-seropositivity might be less prominent in PED nurses compared to NICU nurses, implying a plausible attenuating effect of occupational exposure on CMV-associated immunosenescence. Overall, this pilot study reveals an impact of occupational exposure to viral pathogens on CD4+ T cell immunity and supports further investigation in a larger cohort.
© 2018 British Society for Immunology.

Entities:  

Keywords:  T cell; cytomegalovirus; immune signatures; immunosenescence; varicella zoster virus

Mesh:

Substances:

Year:  2018        PMID: 30076783      PMCID: PMC6194343          DOI: 10.1111/cei.13193

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  56 in total

1.  Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.

Authors:  Giovanna Liuzzo; Francesco Trotta; Daniela Pedicino
Journal:  Eur Heart J       Date:  2012-11-23       Impact factor: 29.983

2.  Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells.

Authors:  Ester M M van Leeuwen; Jasper J Koning; Ester B M Remmerswaal; Debbie van Baarle; René A W van Lier; Ineke J M ten Berge
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

3.  CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.

Authors:  Yvonne Suessmuth; Rithun Mukherjee; Benjamin Watkins; Divya T Koura; Knut Finstermeier; Cindy Desmarais; Linda Stempora; John T Horan; Amelia Langston; Muna Qayed; Hanna J Khoury; Audrey Grizzle; Jennifer A Cheeseman; Jason A Conger; Jennifer Robertson; Aneesah Garrett; Allan D Kirk; Edmund K Waller; Bruce R Blazar; Aneesh K Mehta; Harlan S Robins; Leslie S Kean
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

4.  Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Authors:  Giovanni Almanzar; Susanne Schwaiger; Brigitte Jenewein; Michael Keller; Dietmar Herndler-Brandstetter; Reinhard Würzner; Diether Schönitzer; Beatrix Grubeck-Loebenstein
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 5.  The CD40-CD40L system in cardiovascular disease.

Authors:  Burak Pamukcu; Gregory Y H Lip; Viktor Snezhitskiy; Eduard Shantsila
Journal:  Ann Med       Date:  2011-01-18       Impact factor: 4.709

6.  Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

Authors:  Ester M M van Leeuwen; Ester B M Remmerswaal; Mireille T M Vossen; Ajda T Rowshani; Pauline M E Wertheim-van Dillen; René A W van Lier; Ineke J M ten Berge
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 7.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

Review 8.  Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection.

Authors:  Iain Broadley; Alejandra Pera; George Morrow; Kevin A Davies; Florian Kern
Journal:  Front Immunol       Date:  2017-03-02       Impact factor: 7.561

Review 9.  The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.

Authors:  Yannick Waumans; Lesley Baerts; Kaat Kehoe; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

Review 10.  Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity.

Authors:  Claudio Franceschi; Stefano Salvioli; Paolo Garagnani; Magda de Eguileor; Daniela Monti; Miriam Capri
Journal:  Front Immunol       Date:  2017-08-15       Impact factor: 7.561

View more
  1 in total

1.  Sequential Immunization With Heterologous Viruses Does Not Result in Attrition of the B Cell Memory in Rainbow Trout.

Authors:  Sofie Navelsaker; Susana Magadan; Luc Jouneau; Edwige Quillet; Niels J Olesen; Hetron Mweemba Munang'andu; Pierre Boudinot; Øystein Evensen
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.